Clinical Gynecology
HPV vaccination
Cervical cancer develops gradually, usually starting from specific precancerous lesions (so-called precancers) on its surface.
It is believed to be based on the infection of the cells of the cervix by a certain group of viruses called human papilloma viruses - HPV (human papilloma virus).
Papillomaviruses are a heterogeneous group of viruses that includes many different subtypes.
Some of the papilloma viruses cause only benign changes (e.g. condylomas). Others have oncogenic potential, i.e. cause precancerous changes that can gradually develop into cervical cancer.
Based on these observations, the idea of creating an effective vaccine to protect from infection with certain subtypes of human papillomavirus (HPV) also arose.
- The HPV vaccine should be administered to girls who are already menstruating but have not started having sexual intercourse;
- When having sexual intercourse before vaccination, it is necessary to perform a specialized test called HPV-typing.
For more information about the possibilities of vaccination against HPV at MC MARKOVS as a means of prevention against cervical cancer, you can contact your doctor or call at the registration desk.
